Literature DB >> 10182705

Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction.

.   

Abstract

The Food and Drug Administration (FDA) is correcting a proposed rule that appeared in the Federal Register of July 31, 1998 (63 FR 40858). The document proposed to amend the biologics regulations to eliminate references to establishment licenses and product licenses for all products regulated under the Public Health Services Act. The document published with an incorrect address. This document corrects that error.

Mesh:

Year:  1998        PMID: 10182705

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

1.  The approval process for biosimilar erythropoiesis-stimulating agents.

Authors:  Jay B Wish
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-26       Impact factor: 8.237

2.  Cell-based approaches for augmentation of tendon repair.

Authors:  Camila B Carballo; Amir Lebaschi; Scott A Rodeo
Journal:  Tech Shoulder Elb Surg       Date:  2017-09-01

3.  Biosimilars-Emerging Role in Nephrology.

Authors:  Jay B Wish
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-06       Impact factor: 8.237

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.